Skip to main content

Shafer Michael D's Form 4 filing

Thermo Fisher Scientific Inc. (TMO) · filed Nov 26, 2025

Accession no.
0000097745-25-000172
Filed
Nov 26, 2025
Trade date
Nov 25, 2025
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $6.43M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Shafer Michael DCIK 0002020619Officer (Executive Vice President)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 25, 2025Common StockMOption exerciseAcquired+8,475$253.99+$2,152,565.2527,205.8Direct
Nov 25, 2025Common StockSSaleDisposed−8,475$600.00−$5,085,00018,730.8Direct
Nov 25, 2025Common StockMOption exerciseAcquired+2,250$294.02+$661,54520,980.8Direct
Nov 25, 2025Common StockSSaleDisposed−2,250$600.00−$1,350,00018,730.8Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 25, 2025Common StockMOption exerciseDisposed−8,475$0.00$00Direct
Nov 25, 2025Common StockMOption exerciseDisposed−2,250$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)